Safety and effectiveness of meropenem in infants with suspected or complicated intra-abdominal infections
about
Adverse events associated with meropenem versus imipenem/cilastatin therapy in a large retrospective cohort of hospitalized infantsPrevention and treatment of neonatal nosocomial infections.Advances in pediatric pharmacology, therapeutics, and toxicology.Dosing in neonates: special considerations in physiology and trial design.Open-Label Study To Evaluate the Single-Dose Pharmacokinetics, Safety, and Tolerability of Doripenem in Infants Less than 12 Weeks in Chronological AgeNew antibiotic dosing in infants.Clinical pharmacology of carbapenems in neonates.Adverse drug reactions in neonates: could we be documenting more?Dosing antibiotics in neonates: review of the pharmacokinetic data.Off-label use of antimicrobials in neonates in a tertiary children's hospital.Therapeutic Drug Monitoring of Meropenem in Neonate with Necrotizing Enterocolitis: A Challenge.Electronic Health Records and Pharmacokinetic Modeling to Assess the Relationship between Ampicillin Exposure and Seizure Risk in Neonates.
P2860
Q24601509-4CFB3B3A-B5FF-4CE4-8CD9-2D5FC5F82F48Q30235610-A0F46B54-0895-4B12-BFBF-A71B69F38F36Q33998667-4CF8E6E1-9C36-4D41-A1EF-7E73DF43D131Q34716879-AB78FA84-42BC-4841-9FD1-1B4A3061888FQ35859870-967D3971-B46C-4A80-8146-CDD5A4E6507BQ36438111-BE3DB35C-9DEB-4173-9C26-EEEA36C9477AQ38148807-32189D77-B746-409B-A01C-ABA834F120C5Q38250020-068E1134-C52F-4F30-BCF7-D3C67489B2CCQ38649419-86200E3C-5DB6-4B16-8D27-4FE5F6FB7F46Q39013368-030639D3-8B02-4424-B85F-520736697E71Q39322437-EC04A518-7CF3-48FB-A2D7-AE69D8267D8DQ39492202-94A2F32C-333B-4457-A058-7C4A50A5C47F
P2860
Safety and effectiveness of meropenem in infants with suspected or complicated intra-abdominal infections
description
2012 nî lūn-bûn
@nan
2012 թուականի Դեկտեմբերին հրատարակուած գիտական յօդուած
@hyw
2012 թվականի դեկտեմբերին հրատարակված գիտական հոդված
@hy
2012年の論文
@ja
2012年学术文章
@wuu
2012年学术文章
@zh-cn
2012年学术文章
@zh-hans
2012年学术文章
@zh-my
2012年学术文章
@zh-sg
2012年學術文章
@yue
name
Safety and effectiveness of me ...... ted intra-abdominal infections
@ast
Safety and effectiveness of me ...... ted intra-abdominal infections
@en
Safety and effectiveness of me ...... ted intra-abdominal infections
@nl
type
label
Safety and effectiveness of me ...... ted intra-abdominal infections
@ast
Safety and effectiveness of me ...... ted intra-abdominal infections
@en
Safety and effectiveness of me ...... ted intra-abdominal infections
@nl
prefLabel
Safety and effectiveness of me ...... ted intra-abdominal infections
@ast
Safety and effectiveness of me ...... ted intra-abdominal infections
@en
Safety and effectiveness of me ...... ted intra-abdominal infections
@nl
P2093
P2860
P3181
P356
P1476
Safety and effectiveness of me ...... ted intra-abdominal infections
@en
P2093
Anand Kantak
Antonio Arrieta
Beverly S Brozanski
Brenda Poindexter
Daniel K Benjamin
David A Randolph
David Burchfield
Edmund V Capparelli
Gloria Valencia
Gregory L Kearns
P2860
P304
P3181
P356
10.1093/CID/CIS758
P407
P577
2012-12-01T00:00:00Z